Top compounds associated with response to RLN3


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib gCSI pan-cancer AAC 0.021 0.7
mRNA MG-132 CTRPv2 pan-cancer AAC 0.02 0.7
mRNA OSI-930 GDSC1000 pan-cancer AAC -0.012 0.7
mRNA ZM-447439 GDSC1000 pan-cancer AAC -0.012 0.7
mRNA BX-912 GDSC1000 pan-cancer AAC -0.01 0.7
mRNA JNJ-26854165 GDSC1000 pan-cancer AAC -0.011 0.7
mRNA Vandetanib CCLE pan-cancer AAC -0.015 0.7
mRNA BRD-K75293299 CTRPv2 pan-cancer AAC 0.023 0.7
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.7
mRNA quizartinib CTRPv2 pan-cancer AAC -0.012 0.7
Download CSV